We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$664M
AUM Growth
-$538M
(-45%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-72.87%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$11.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$11.4M |
| 3 |
Privia Health
PRVA
|
+$10M |
| 4 |
Definitive Healthcare
DH
|
+$9.98M |
| 5 |
Arrowhead Research
ARWR
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$17.9M |
| 2 |
Arcus Biosciences
RCUS
|
+$17.7M |
| 3 |
ResMed
RMD
|
+$15.8M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$14.5M |
| 5 |
Evolent Health
EVH
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.16% |
| 2 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Incyte
INCY
$24.2B
| $430K | 0.06% |
5,860
-2,350
| -29% | -$158K |
|
|
AFMD
102
DELISTED
Affimed
AFMD
| $373K | 0.06% |
6,750
+2,250
| +50% | +$139K |
|
103
Legend Biotech
LEGN
$3.59B
| $326K | 0.05% |
7,000
-400
| -5% | -$20.3K |
|
104
Vir Biotechnology
VIR
$1.46B
| $251K | 0.04% |
+6,000
| New | +$235K |
|
105
CRISPR Therapeutics
CRSP
$4.73B
| $248K | 0.04% |
3,270
| – | – |
|
106
Aligos Therapeutics
ALGS
$26.2M
| $201K | 0.03% |
676
| – | – |
|
107
Dr. Reddy's Laboratories
RDY
$9.87B
| $196K | 0.03% |
15,020
-17,250
| -53% | -$217K |
|
|
FUSN
108
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $159K | 0.02% |
38,198
| – | – |
|
109
argenx
ARGX
$53.4B
| – | – |
-1,570
| Closed | -$474K |
|
110
Aveanna Healthcare
AVAH
$2.04B
| – | – |
-1,172,609
| Closed | -$9.4M |
|
111
Bristol-Myers Squibb
BMY
$133B
| – | – |
-73,074
| Closed | -$4.32M |
|
112
Bolt Biotherapeutics
BOLT
$7.67M
| – | – |
-5,796
| Closed | -$1.47M |
|
113
BeyondSpring
BYSI
$47.3M
| – | – |
-217,250
| Closed | -$3.42M |
|
114
Cigna
CI
$73.7B
| – | – |
-11,547
| Closed | -$2.31M |
|
115
Centene
CNC
$30.7B
| – | – |
-113,075
| Closed | -$7.05M |
|
116
Cooper Companies
COO
$14.1B
| – | – |
-91,520
| Closed | -$9.46M |
|
117
Charles River Laboratories
CRL
$11.2B
| – | – |
-22,800
| Closed | -$9.41M |
|
118
Cytek Biosciences
CTKB
$545M
| – | – |
-328,080
| Closed | -$7.02M |
|
119
Cytosorbents Corp
CTSO
$22.7M
| – | – |
-244,660
| Closed | -$1.99M |
|
|
EXAS
120
DELISTED
Exact Sciences
EXAS
| – | – |
-67,700
| Closed | -$6.46M |
|
|
HOLX
121
DELISTED
Hologic
HOLX
| – | – |
-95,800
| Closed | -$7.07M |
|
122
Labcorp
LH
$25B
| – | – |
-48,320
| Closed | -$11.7M |
|
123
Molina Healthcare
MOH
$10.2B
| – | – |
-30,697
| Closed | -$8.33M |
|
124
Nkarta
NKTX
$150M
| – | – |
-384,364
| Closed | -$10.7M |
|
125
Neuropace
NPCE
$439M
| – | – |
-444,572
| Closed | -$7.05M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sectoral Asset Management held 142 positions worth $664M, down 45% from $1.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management withdrew a net $484M in Q4 2021, closing 34 positions and reducing 58 holdings. Its most notable exit was ResMed, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Certara worth $9.96M.
- Sectoral Asset Management's largest Q4 2021 buy was Certara: 350,438 shares worth $9.96M.
- Sectoral Asset Management added most to Mirati Therapeutics, Inc. Common Stock in Q4 2021, an estimated $11.4M increase.
- Sectoral Asset Management's biggest Q4 2021 reduction was Agilent Technologies, cutting an estimated $17.9M.
- Sectoral Asset Management fully exited ResMed in Q4 2021, selling an estimated $15.8M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $664M portfolio in Q4 2021.
- Sectoral Asset Management opened 15 new positions and closed 34 in Q4 2021.
- Sectoral Asset Management's portfolio value fell 45% quarter-over-quarter to $664M.
Based on Sectoral Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.